{'fraction_non_alphanumeric': 0.02145922746781116, 'fraction_numerical': 0.012875536480686695, 'mean_word_length': 5.3108108108108105, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Role of autologous mesenchymal stem cells associated with platelet‐rich plasma on healing of cutaneous wounds in diabetic mice

Background. Chronic cutaneous lesions affect 15% of human patients with diabetes, and the associated risk of limb amputations is 15–46 times greater than that of people with normal glycaemia. It is estimated that half of these limb amputations could be avoided by opportune treatment with somatic stem cells or platelet‐rich plasma (PRP).